The Second Circuit last week prescribed death for a class action alleging that Eli Lilly and Company fooled doctors into treating patients with Lily's anti-schizophrenia drug Zyprexa.

The plaintiffs — unions and others that pay all or part of patients' pharmaceutical bills — alleged that Lilly violated the Racketeer-Influenced and Corrupt Organizations Act by hiding and misrepresenting

The Seventh Circuit struck a blow last month for certifying securities fraud cases as class actions — and against the Fifth Circuit's attempt, the panel believed, "to 'tighten the requirements' for class certification" in such cases.

The court held the district court did right by rejecting the defendants' "arguments that if accepted would end the use

The Third Circuit has ordered rehearing by the full court in a sprawling antitrust case against price-fixer and market-allocator DeBeers. 

The order vacated a panel decision that mainly upheld denial of class certification.  Blawgletter did a short review of the decision in Third Circuit Cuts Global Diamond Class.  There we said:

DeBeers, the diamond behemoth,

Blawgletter got back this morning (around 3:00 a.m.) from our first-ever trip to Boise.  We saw a Great Many lawyers.

We and they had come to watch, and some of us to present, argument about what the Judicial Panel on Multidistrict Litigation should do with big cases. 

In re Oil Spill by the Oil Rig "Deepwater Horizon" in the

The Supreme Court of California ruled last week that the Golden State's antitrust statute, the Cartwright Act, allows an award of overcharge damages to people who don't buy directly from a price-fixer.  Clayworth v. Pfizer, Inc., No. S166435 (Cal. July 12, 2010).

The case involved pharmacies that alleged price-fixing by drug manufacturers.  The